Quit Genius, a NYC-based digital clinic for treating multiple addictions, raised $64M in Series B funding round.
The round was co-led by Kinnevik and Atomico, with participation from Series A investors Octopus Ventures, Triple Point Ventures and Startup Health.
The company will use the funds to fuel expansion of its platform in the U.S..
Led by Yusuf Sherwani, M.D., Co-founder and CEO, Quit Genius is a digital clinic for treating nicotine, alcohol and opioid addictions. Built on the evidence-based practice of Medication-Assisted Treatment (MAT), the company combines virtual behavioral therapy with approved medication and connected devices to help employers tackle the cost of addiction in the workplace while improving the lives of their employees.
Quit Genius integrates with health plans, pharmacy benefit managers and wellness platforms to deliver a implementation experience.
FinSMEs
20/07/2021